Insider Transactions in Q3 2022 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2022
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,697
-0.57%
|
$304,667
$11.08 P/Share
|
|
Aug 16
2022
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,705
+1.4%
|
-
|
|
Aug 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,227
-2.63%
|
$101,497
$11.08 P/Share
|
|
Aug 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,680
+7.07%
|
-
|
|
Aug 16
2022
|
Richard H Scheller Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,101
-2.16%
|
$12,111
$11.08 P/Share
|
|
Aug 16
2022
|
Richard H Scheller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,196
+5.9%
|
-
|
|
Aug 16
2022
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,287
-0.11%
|
$14,157
$11.08 P/Share
|
|
Aug 16
2022
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+0.31%
|
-
|